Literature DB >> 22893340

Effect of nurse practitioner and pharmacist counseling on inappropriate medication use in family practice.

John Fletcher1, William Hogg, Barbara Farrell, Kirsten Woodend, Simone Dahrouge, Jacques Lemelin, William Dalziel.   

Abstract

OBJECTIVE: To measure the effect of nurse practitioner and pharmacist consultations on the appropriate use of medications by patients.
DESIGN: We studied patients in the intervention arm of a randomized controlled trial. The main trial intervention was provision of multidisciplinary team care and the main outcome was quality and processes of care for chronic disease management.
SETTING: Patients were recruited from a single publicly funded family health network practice of 8 family physicians and associated staff serving 10 000 patients in a rural area near Ottawa, Ont. PARTICIPANTS: A total of 120 patients 50 years of age or older who were on the practice roster and who were considered by their family physicians to be at risk of experiencing adverse health outcomes. INTERVENTION: A pharmacist and 1 of 3 nurse practitioners visited each patient at his or her home, conducted a comprehensive medication review, and developed a tailored plan to optimize medication use. The plan was developed in consultation with the patient and the patient's doctor. We assessed medication appropriateness at the study baseline and again 12 to 18 months later. MAIN OUTCOME MEASURES: We used the medication appropriateness index to assess medication use. We examined associations between personal characteristics and inappropriate use at baseline and with improvements in medication use at the follow-up assessment. We recorded all drug problems encountered during the trial.
RESULTS: At baseline, 27.2% of medications were inappropriate in some way and 77.7% of patients were receiving at least 1 medication that was inappropriate in some way. At the follow-up assessments these percentages had dropped to 8.9% and 38.6%, respectively (P < .001). Patient characteristics that were associated with receiving inappropriate medication at baseline were being older than 80 years of age (odds ratio [OR] = 5.00, 95% CI 1.19 to 20.50), receiving more than 4 medications (OR = 6.64, 95% CI 2.54 to 17.4), and not having a university-level education (OR = 4.55, 95% CI 1.69 to 12.50).
CONCLUSION: We observed large improvements in the appropriate use of medications during this trial. This might provide a mechanism to explain some of the reductions in mortality and morbidity observed in other trials of counseling and advice provided by pharmacists and nurses. TRIAL REGISTRATION NUMBER: NCT00238836 (ClinicalTrials.gov).

Entities:  

Mesh:

Year:  2012        PMID: 22893340      PMCID: PMC3418988     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  15 in total

1.  A database analysis of potentially inappropriate drug use in an elderly medicaid population.

Authors:  L T Piecoro; S R Browning; T S Prince; T T Ranz; F D Scutchfield
Journal:  Pharmacotherapy       Date:  2000-02       Impact factor: 4.705

2.  Inappropriate prescriptions for the aging population of the United States: an analysis of the National Ambulatory Medical Care Survey, 1997.

Authors:  Boji Huang; Kenneth A Bachmann; Xuming He; Randi Chen; Jennifer S McAllister; Tongtong Wang
Journal:  Pharmacoepidemiol Drug Saf       Date:  2002-03       Impact factor: 2.890

3.  Medication appropriateness index: reliability and recommendations for future use.

Authors:  Anne Spinewine; Christophe Dumont; Louise Mallet; Christian Swine
Journal:  J Am Geriatr Soc       Date:  2006-04       Impact factor: 5.562

4.  "Take ten minutes": a dedicated ten minute medication review reduces polypharmacy in the elderly.

Authors:  E K Walsh; K Cussen
Journal:  Ir Med J       Date:  2010-09

5.  Reliability of a modified medication appropriateness index in primary care.

Authors:  Lisbeth Bregnhøj; Steffen Thirstrup; Mogens Brandt Kristensen; Jesper Sonne
Journal:  Eur J Clin Pharmacol       Date:  2005-10-01       Impact factor: 2.953

6.  Effectiveness of telephone counselling by a pharmacist in reducing mortality in patients receiving polypharmacy: randomised controlled trial.

Authors:  Jennifer Y F Wu; Wilson Y S Leung; Sophie Chang; Benjamin Lee; Benny Zee; Peter C Y Tong; Juliana C N Chan
Journal:  BMJ       Date:  2006-08-17

7.  A summated score for the medication appropriateness index: development and assessment of clinimetric properties including content validity.

Authors:  G P Samsa; J T Hanlon; K E Schmader; M Weinberger; E C Clipp; K M Uttech; I K Lewis; P B Landsman; H J Cohen
Journal:  J Clin Epidemiol       Date:  1994-08       Impact factor: 6.437

8.  Reliability of a modified medication appropriateness index in ambulatory older persons.

Authors:  L S Fitzgerald; J T Hanlon; P S Shelton; P B Landsman; K E Schmader; C C Pulliam; M E Williams
Journal:  Ann Pharmacother       Date:  1997-05       Impact factor: 3.154

Review 9.  Sensitivity of patient outcomes to pharmacist interventions. Part I: systematic review and meta-analysis in diabetes management.

Authors:  Márcio Machado; Jana Bajcar; Giovanni C Guzzo; Thomas R Einarson
Journal:  Ann Pharmacother       Date:  2007-08-21       Impact factor: 3.154

10.  Reliability of a modified medication appropriateness index in community pharmacies.

Authors:  Rosemin Kassam; Linda G Martin; Karen B Farris
Journal:  Ann Pharmacother       Date:  2003-01       Impact factor: 3.154

View more
  12 in total

1.  Practice nurses and pharmacists: a perspective on the expectation and experience of nurses for future collaboration.

Authors:  Abdul Nabeel Khan; Muhammad Umair Khan; Muhammad Harris Shoaib; Rabia Ismail Yousuf; Salman Ali Mir
Journal:  Oman Med J       Date:  2014-07

2.  Attitudes of medical doctors and nurses towards the role of the nurses in the primary care unit in Italy.

Authors:  Maria R Gualano; Fabrizio Bert; Valeria Adige; Robin Thomas; Gitana Scozzari; Roberta Siliquini
Journal:  Prim Health Care Res Dev       Date:  2017-12-22       Impact factor: 1.458

Review 3.  Potential use of NOACs in developing countries: pros and cons.

Authors:  Durga Bista; Leanne Chalmers; Luke Bereznicki; Gregory Peterson
Journal:  Eur J Clin Pharmacol       Date:  2014-05-11       Impact factor: 2.953

Review 4.  Assessment of pharmacist-led patient counseling in randomized controlled trials: a systematic review.

Authors:  Lucas Miyake Okumura; Inajara Rotta; Cassyano Januário Correr
Journal:  Int J Clin Pharm       Date:  2014-07-23

5.  Adherence and non-adherence to treatments: focus on pharmacy practice in Nepal.

Authors:  Suresh Bastakoti; Saval Khanal; Bibek Dahal; Nirmala Tilija Pun
Journal:  J Clin Diagn Res       Date:  2013-04-01

6.  Activities performed by pharmacists integrated in family health teams: Results from a web-based survey.

Authors:  Ulrika Gillespie; Lisa Dolovich; Simone Dahrouge
Journal:  Can Pharm J (Ott)       Date:  2017-10-05

Review 7.  Interventions to improve the appropriate use of polypharmacy for older people.

Authors:  Audrey Rankin; Cathal A Cadogan; Susan M Patterson; Ngaire Kerse; Chris R Cardwell; Marie C Bradley; Cristin Ryan; Carmel Hughes
Journal:  Cochrane Database Syst Rev       Date:  2018-09-03

Review 8.  Exploration of workforce changes in integrated chronic care: Findings from an interactive and emergent research design.

Authors:  Loraine Busetto; Katrien Luijkx; Stefano Calciolari; Laura Guadalupe González Ortiz; Hubertus Johannes Maria Vrijhoef
Journal:  PLoS One       Date:  2017-12-21       Impact factor: 3.240

9.  Barriers and Facilitators to Workforce Changes in Integrated Care.

Authors:  Loraine Busetto; Katrien Luijkx; Stefano Calciolari; Laura Guadalupe González Ortiz; Hubertus Johannes Maria Vrijhoef
Journal:  Int J Integr Care       Date:  2018-06-01       Impact factor: 5.120

10.  Pharmacy and nursing students' attitudes toward nurse-pharmacist collaboration at a Chinese university.

Authors:  Shu-Ping Wang; Jun Wang; Qiu-Hong Huang; Ying-Hong Zhang; Juan Liu
Journal:  BMC Med Educ       Date:  2018-08-02       Impact factor: 2.463

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.